MedPath

SEACALPHYX

SEACALPHYX

Approved
DIN Number

02386666

Drug Class

Human

Market Date

Jan 8, 2013

Company
HC

seaford pharmaceuticals inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02386666
AIG Number0109248001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
V03AB06 THIOSULPHATE
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification91:04.12
Health Canada Classification

ACTIVE INGREDIENTS (1)

SODIUM THIOSULFATEActive
Strength: 250 MG / ML
Monograph: SODIUM THIOSULFATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.